Video
Standard Prognoses for Pediatric and Adult Patients with Acute Lymphoblastic Leukemia
Author(s):
Ryan Cassaday, MD, notes differences between prognoses for patients with ALL based-on age, subtype, and disease progression status.
Video Player is loading.
Related Videos
Real-World Data in Myelofibrosis: Bridging the Gap Between Clinical Trials and Practice
Advancing Myelofibrosis Treatment: Personalized Strategies with Fedratinib and Ruxolitinib
Reflections and Future Directions in R/R ALL
Outpatient CAR T Therapy and Expanding Access
Health Care Resource Utilization and Transition of Care
Treatment Overview in Later-Stage Relapsed/Refractory Multiple Myeloma
Emerging Data on BTK Inhibitor Degraders and Bispecifics in R/R CLL: Updated Results at ASH 2024
Exploring Data of PI3K/AKT/mTOR Inhibitors in HER2– mBC
The Evolving Landscape: CAR T and Future Therapies in Early-Stage R/R Myeloma
Genotype-Directed Therapies for HR+/HER2– Advanced Breast Cancer
Related Content
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
